Scientists May Now Know Why GLP-1s Don't Work For 10% of People

Science

Scientists May Now Know Why Glp-1S Don't Work For 10% Of People

By ScienceAlert

Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments (such as Ozempic and Wegovy) less effective, according to new research. These treatments are named after the glucagon-like pept ...Read more

Related Posts

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway

Apr 14, 2026
Genetics may help explain why results from weight-loss jabs vary, say scientists

Genetics may help explain why results from weight-loss jabs vary, say scientists

Apr 08, 2026
'They could spend 4 or 5 hours per day underwater': How humans adapted to the most challenging environments

'They could spend 4 or 5 hours per day underwater': How humans adapted to the most challenging environments

Apr 06, 2026
SP8 Breakthrough: A Foundational Step Toward Human Limb Regeneration

SP8 Breakthrough: A Foundational Step Toward Human Limb Regeneration

Apr 19, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.